Publicaciones en colaboración con investigadores/as de Centro de Investigacion Biomedica en Red de Salud Mental (10)

2023

  1. Psychosis and substance abuse increase the COVID-19 mortality risk

    Psychological Medicine, Vol. 53, Núm. 9, pp. 4236-4244

2022

  1. Cannabis use selectively modulates circulating biomarkers in the blood of schizophrenia patients

    Addiction Biology, Vol. 27, Núm. 6

  2. Ten-year course of cognition in first-episode non-affective psychosis patients: PAFIP cohort

    Psychological Medicine, Vol. 52, Núm. 4, pp. 770-779

2021

  1. Early intervention services, patterns of prescription and rates of discontinuation of antipsychotic treatment in first-episode psychosis

    Early Intervention in Psychiatry, Vol. 15, Núm. 6, pp. 1584-1594

2019

  1. Pattern of use of clozapine in Spain. Variability and under-prescription

    Revista de Psiquiatria y Salud Mental, Vol. 12, Núm. 3, pp. 151-162

2018

  1. Mechanisms of functional improvement through cognitive rehabilitation in schizophrenia

    Journal of Psychiatric Research, Vol. 101, pp. 21-27

2016

  1. Combining social cognitive treatment, cognitive remediation, and functional skills training in schizophrenia: A randomized controlled trial

    npj Schizophrenia, Vol. 2

2015

  1. Dysbindin gene variability is associated with cognitive abnormalities in first-episode non-affective psychosis

    Cognitive Neuropsychiatry, Vol. 20, Núm. 2, pp. 144-156

2010

  1. Cognitive functioning in children and adolescents in their first episode of psychosis: Differences between previous cannabis users and nonusers

    Journal of Nervous and Mental Disease, Vol. 198, Núm. 2, pp. 159-162

  2. Neuropsychological functioning in early-onset first-episode psychosis: Comparison of diagnostic subgroups

    European Archives of Psychiatry and Clinical Neuroscience, Vol. 260, Núm. 3, pp. 225-233